Trials / Unknown
UnknownNCT00891852
Non-Invasive Determination of Fetal Chromosome Abnormalities
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Lenetix Medical Screening Laboratory · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.
Conditions
- Down Syndrome (Trisomy 21)
- Edward's Syndrome (Trisomy 18)
- Patau Syndrome (Trisomy 13)
- Klinefelter Syndrome (47, XXY)
- and Other Chromosome
- Abnormalities.
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-05-01
- Last updated
- 2009-05-01
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00891852. Inclusion in this directory is not an endorsement.